Investor Relations Press Releases Mar 20, 2023 Asensus Surgical Receives FDA 510(k) Clearance For Pediatric Indication for Senhance Surgical System Mar 06, 2023 Asensus Surgical to Participate in the Oppenheimer 33rd Annual Healthcare Conference Investor Fact Sheet Investor Fact Sheet Events & Presentations More information is coming soon. View all press releases + View all events & presentations + Intra 3 mo. 6 mo. 1 yr. Data Provided by Refinitiv. Minimum 15 minutes delayed. SEC Filings Filing date Form Description View Apr 9, 1997 S-3/A Pre-effective amendment to an S-3 filing View HTML 0000910680-97-000130.pdf 0000910680-97-000130.rtf Mar 7, 2014 S-3/A Pre-effective amendment to an S-3 filing View HTML 0001193125-14-089437.pdf 0001193125-14-089437.rtf 0001193125-14-089437.xls Mar 31, 2014 S-3/A Pre-effective amendment to an S-3 filing View HTML 0001193125-14-122578.pdf 0001193125-14-122578.rtf 0001193125-14-122578.xls View all SEC filings + Corporate Governance Documents Document View Audit Committee Charter Audit Committee Charter 129.4 KB Compensation Committee Charter Compensation Committee Charter 119.5 KB Corporate Governance and Nominating Committee Charter Corporate Governance and Nominating Committee Charter 119 KB Code of Business Conduct and Ethics Code of Business Conduct and Ethics 329.4 KB Communications with the Board Communications with the Board 7.9 KB
Mar 20, 2023 Asensus Surgical Receives FDA 510(k) Clearance For Pediatric Indication for Senhance Surgical System
